“…Since under mild conditions sulfonamides can be recovered easily from the reaction mixture they are used as protecting groups for the ANHA functionality [11]. Several drugs including therapeutic agents for Alzheimer's disease [12], inhibitors of tRNA synthetases, antibacterial agents [13], prostaglandin F1a sulfonamides for the potential treatment of osteoporosis [14], antagonists for angiotensin II [15], and leukotriene D4-receptors [16] possess the N-sulfonyl moiety. Protocols documented in the literature for the N-sulfonylation involves use of metal oxides (MgO, Ag 2 O, CuO, ZnO), Zn-Al hydrotalcite, CsFCelite as catalysts and N-chlorosulfonyl carbamate (CSC) [17].…”